Skip to Content

Comirnaty XFG 30 micrograms / dose dispersion for injection

Licence status
Authorised: 21/12/2020
Active substances
Single-stranded, 5’-capped messenger RNA produced using a cell-free in vitro transcription from the corresponding DNA templates, encoding the viral spike (S) protein of SARS-CoV-2
Dosage Form
Dispersion for injection in pre-filled syringe
Licence number
EU/1/20/1528/052-055
Licence holder
BioNTech Manufacturing GmbH

Licence information

ATC code
J07BN01 covid-19, RNA-based vaccine
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to medical prescription. In accordance with Article 114 of Directive 2001/83/EC, the official batch release will be undertaken by a state laboratory or a laboratory designated for that purpose.
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
21/12/2020